O Tschopp
04.05.2013
Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
Köhler S, Tschopp O, Sze L, Neidert M, Bernays R, Spanaus K, Wiesli P, Schmid C. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?. Gen Comp Endocrinol 2013; 188:282-7.
04.05.2013Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
04.05.2013Gen Comp Endocrinol 2013; 188:282-7
Köhler S, Tschopp O, Sze Lisa, Neidert M, Bernays R-L, Spanaus K-S, Wiesli P, Schmid C
Weiter
27.04.2000
Osteonecrosis after lung transplantation: cystic fibrosis as a potential risk factor
Schoch O, Speich R, Schmid C, Tschopp O, Russi E, Weder W, Boehler A. Osteonecrosis after lung transplantation: cystic fibrosis as a potential risk factor. Transplantation 2000; 69:1629-32.
27.04.2000Osteonecrosis after lung transplantation: cystic fibrosis as a potential risk factor
27.04.2000Transplantation 2000; 69:1629-32
Schoch Otto, Speich R, Schmid C, Tschopp O, Russi E W, Weder W, Boehler A
Weiter